EVELO BIOSCIENCES INC's ticker is EVLO and the CUSIP is 299734103. A total of 69 filers reported holding EVELO BIOSCIENCES INC in Q2 2021. The put-call ratio across all filers is 0.73 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2021 | $6,070,000 | -13.8% | 1,000,000 | 0.0% | 0.16% | +4.4% |
Q3 2021 | $7,040,000 | -48.8% | 1,000,000 | 0.0% | 0.16% | -43.4% |
Q2 2021 | $13,740,000 | +28.4% | 1,000,000 | 0.0% | 0.28% | +47.6% |
Q1 2021 | $10,700,000 | +26.4% | 1,000,000 | +42.9% | 0.19% | +3.8% |
Q4 2020 | $8,463,000 | +238.1% | 700,000 | +47.4% | 0.18% | +198.4% |
Q3 2020 | $2,503,000 | -23.4% | 475,000 | -28.7% | 0.06% | -33.0% |
Q2 2020 | $3,267,000 | – | 666,666 | – | 0.09% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
HARBOURVEST PARTNERS LLC | 1,763,505 | $21,479,000 | 19.42% |
Flagship Pioneering Inc. | 18,233,403 | $222,083,000 | 14.68% |
Alphabet Inc. | 1,060,495 | $12,917,000 | 1.24% |
SECTORAL ASSET MANAGEMENT INC | 407,171 | $4,959,000 | 0.53% |
ARK Investment Management | 236,685 | $2,883,000 | 0.09% |
CREDIT SUISSE AG/ | 888,287 | $10,819,000 | 0.01% |
Tower Research Capital LLC (TRC) | 3,931 | $48,000 | 0.00% |
FMR LLC | 3,264,907 | $38,611,000 | 0.00% |
VICTORY CAPITAL MANAGEMENT INC | 89,780 | $1,094,000 | 0.00% |
WILBANKS SMITH & THOMAS ASSET MANAGEMENT LLC | 900 | $11,000 | 0.00% |